• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不使用抗生素对耐万古霉素肠球菌和耐碳青霉烯类肠杆菌科细菌进行全面、多系统的机械去定植

Comprehensive, multisystem, mechanical decolonization of Vancomycin-Resistant Enterococcus and Carbapenem-Resistant Enterobacteriacease without the use of antibiotics.

作者信息

Choi Eunseok, Lee Sook Joung, Lee Sangjee, Yi Jinseok, Lee Yeon Soo, Chang So-Youn, Jeong Ho Young, Joo Yunwoo

机构信息

Department of Physical Medicine and Rehabilitation.

Department of Neurosurgery.

出版信息

Medicine (Baltimore). 2021 Jan 22;100(3):e23686. doi: 10.1097/MD.0000000000023686.

DOI:10.1097/MD.0000000000023686
PMID:33545935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7837958/
Abstract

Among multidrug-resistant organisms (MDROs), Vancomycin-resistant Enterococcus (VRE), and Carbapenem-resistant Enterobacteriaceae (CRE) have become major nosocomial pathogens that are endemic worldwide. If VRE/CRE are present as colonizing organisms but do not act as pathogens, these organisms do not cause symptoms and do not require antibiotic use. However, once gastrointestinal colonization with VRE/CRE occurs, it can persist for long periods and serve as a reservoir for transmission to other patients. Therefore, a breakthrough strategy to control the spread of MDRO colonization is needed. We herein introduce decolonization method, which is a comprehensive, multisystem, consecutive mechanical MDRO decolonization protocol that does not utilize antibiotics. Our protocol included: (1).. Mechanical evacuation using a glycerin enema, (2).. Replacement of the normal gut flora using daily lactobacillus ingestion, (3).. Skin hygiene cleansing using chlorhexidine, and (4).. Environmental cleansing by changing the bed sheets and clothing every day. These steps were repeated consecutively until the patient was released from quarantine. We conducted VRE/CRE tests every week. Because our protocol was a comprehensive and multisystem decolonization protocol, the cooperation of patients and/or caregivers was essential, and family support was important for patient care. Patients were divided into VRE and CRE groups and were subdivided into success and failure groups according to decolonization status. Thirty-two patients with VRE or CRE colonization were enrolled, and our protocol was performed. A total of 20 patients (62.5%) were successfully decolonized after repeated protocols. Univariate analysis revealed that patients with younger age, higher body mass index (BMI), shorter period of MDRO isolation without trial, and higher functional status showed significantly enhanced success rates with our decolonization protocol. This study presents the decolonization effects of a comprehensive, multisystem, mechanical decolonization protocol for VRE and CRE. Most importantly, our decolonization protocol does not use antibiotics and is thus not harmful. These results suggest an active decolonization trial to be performed as early as possible in patients with VRE or CRE colonization. This simple, easy-to-apply protocol can be used as 1 of the basic treatment options for MDROs infection or colonization, regardless of whether it requires antibiotic treatment.

摘要

在多重耐药菌(MDROs)中,耐万古霉素肠球菌(VRE)和耐碳青霉烯类肠杆菌科细菌(CRE)已成为全球范围内流行的主要医院感染病原体。如果VRE/CRE作为定植菌存在但不作为病原体,这些细菌不会引起症状,也不需要使用抗生素。然而,一旦发生VRE/CRE胃肠道定植,它可能会长期持续存在,并成为传播给其他患者的传染源。因此,需要一种突破性策略来控制MDRO定植的传播。我们在此介绍去定植方法,这是一种全面、多系统、连续的机械性MDRO去定植方案,不使用抗生素。我们的方案包括:(1)使用甘油灌肠进行机械性排空,(2)每天摄入乳酸菌以替代正常肠道菌群,(3)使用氯己定进行皮肤卫生清洁,以及(4)每天更换床单和衣物进行环境清洁。这些步骤连续重复,直到患者解除隔离。我们每周进行VRE/CRE检测。由于我们的方案是一种全面、多系统的去定植方案,患者和/或护理人员的合作至关重要,家庭支持对患者护理也很重要。患者被分为VRE组和CRE组,并根据去定植状态进一步细分为成功组和失败组。32例VRE或CRE定植患者入组并执行我们的方案。经过反复方案后,共有20例患者(62.5%)成功去定植。单因素分析显示,年龄较小、体重指数(BMI)较高、MDRO隔离未经试验的时间较短以及功能状态较高的患者,我们的去定植方案成功率显著提高。本研究展示了一种针对VRE和CRE的全面、多系统、机械性去定植方案的去定植效果。最重要的是,我们的去定植方案不使用抗生素,因此无害。这些结果表明,对于VRE或CRE定植患者应尽早进行积极的去定植试验。这种简单、易于应用的方案可作为MDRO感染或定植的基本治疗选择之一,无论是否需要抗生素治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7837958/6817595c0ca2/medi-100-e23686-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7837958/bd630435c538/medi-100-e23686-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7837958/6817595c0ca2/medi-100-e23686-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7837958/bd630435c538/medi-100-e23686-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7837958/6817595c0ca2/medi-100-e23686-g002.jpg

相似文献

1
Comprehensive, multisystem, mechanical decolonization of Vancomycin-Resistant Enterococcus and Carbapenem-Resistant Enterobacteriacease without the use of antibiotics.不使用抗生素对耐万古霉素肠球菌和耐碳青霉烯类肠杆菌科细菌进行全面、多系统的机械去定植
Medicine (Baltimore). 2021 Jan 22;100(3):e23686. doi: 10.1097/MD.0000000000023686.
2
Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study.粪便微生物移植后耐碳青霉烯类肠杆菌科与耐万古霉素肠球菌定植清除的比较:一项前瞻性对照研究。
J Hosp Infect. 2018 Aug;99(4):481-486. doi: 10.1016/j.jhin.2018.02.018. Epub 2018 Mar 2.
3
Germs of thrones - spontaneous decolonization of Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococci (VRE) in Western Europe: is this myth or reality?王位的细菌——西欧碳青霉烯类耐药肠杆菌科(CRE)和万古霉素耐药肠球菌(VRE)的自发去殖民化:这是神话还是现实?
Antimicrob Resist Infect Control. 2018 Aug 13;7:100. doi: 10.1186/s13756-018-0390-5. eCollection 2018.
4
Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.异基因造血干细胞移植受者中针对碳青霉烯类耐药肠杆菌科定植的串联粪便微生物移植周期:一例病例报告及文献复习。
Eur J Med Res. 2021 Apr 28;26(1):37. doi: 10.1186/s40001-021-00508-8.
5
Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?粪便微生物群移植是根除高度耐药性肠道细菌携带的一种选择吗?
J Hosp Infect. 2017 Apr;95(4):433-437. doi: 10.1016/j.jhin.2017.02.001. Epub 2017 Feb 6.
6
Controlling Nosocomial Transmission of Drug-Resistant Pathogens at Different Endemic Stages in a Resource-Limited Setting.在资源有限的环境中控制耐药病原体在不同流行阶段的医院内传播。
Infect Control Hosp Epidemiol. 2016 Sep;37(9):1114-6. doi: 10.1017/ice.2016.121. Epub 2016 Jun 20.
7
Active surveillance for carbapenem-resistant Enterobacteriaceae, vancomycin-resistant enterococci and toxigenic Clostridium difficile among patients transferred from long-term care facilities in Korea.对从韩国长期护理机构转来的患者进行耐碳青霉烯肠杆菌科、耐万古霉素肠球菌和产毒艰难梭菌的主动监测。
J Hosp Infect. 2018 Aug;99(4):487-491. doi: 10.1016/j.jhin.2018.02.017. Epub 2018 Feb 21.
8
Prevalence of and Factors Associated With Multidrug Resistant Organism (MDRO) Colonization in 3 Nursing Homes.3家养老院中多重耐药菌(MDRO)定植的患病率及相关因素
Infect Control Hosp Epidemiol. 2016 Dec;37(12):1485-1488. doi: 10.1017/ice.2016.215. Epub 2016 Sep 27.
9
Extensively-drug-resistant bacteria carriers among overseas travellers: one-third had not been hospitalized previously.旅行中广泛耐药菌携带者:三分之一的人以前没有住院。
Int J Antimicrob Agents. 2018 Sep;52(3):385-389. doi: 10.1016/j.ijantimicag.2018.06.006. Epub 2018 Jun 12.
10
Strategies for the eradication of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae intestinal carriage.产超广谱β-内酰胺酶或碳青霉烯酶肠杆菌科肠道定植的清除策略。
Expert Rev Anti Infect Ther. 2019 Aug;17(8):557-569. doi: 10.1080/14787210.2019.1645007. Epub 2019 Jul 25.

引用本文的文献

1
Effect of Repeated Education on ICU Nurses' Knowledge and Performance in MDRO Infection Control: A Pretest-Posttest Study.重复教育对重症监护病房护士在多重耐药菌感染控制方面的知识及表现的影响:一项前后测研究。
Nurs Crit Care. 2025 Jul;30(4):e70123. doi: 10.1111/nicc.70123.
2
Decolonization strategies for ESBL-producing or carbapenem-resistant Enterobacterales carriage: a systematic review and meta-analysis.产 ESBL 或碳青霉烯类耐药肠杆菌科定植的去殖民化策略:系统评价和荟萃分析。
Sci Rep. 2024 Oct 17;14(1):24349. doi: 10.1038/s41598-024-75791-6.
3
Infection Prevention and Control Strategies According to the Type of Multidrug-Resistant Bacteria and in Intensive Care Units: A Pragmatic Resume including Pathogens R and a Cost-Effectiveness Analysis.

本文引用的文献

1
COVID-19: towards controlling of a pandemic.2019冠状病毒病:迈向大流行的控制
Lancet. 2020 Mar 28;395(10229):1015-1018. doi: 10.1016/S0140-6736(20)30673-5. Epub 2020 Mar 17.
2
Carbapenemase-producing Enterobacteriaceae - once positive always positive?产碳青霉烯酶肠杆菌科细菌——一阳永阳?
Curr Opin Gastroenterol. 2020 Jan;36(1):9-16. doi: 10.1097/MOG.0000000000000596.
3
Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future Perspectives.肠道微生物群调节以实现多重耐药菌清除:现状与未来展望
根据多重耐药菌类型的重症监护病房感染预防与控制策略:一份包括病原体R的实用概述及成本效益分析
Antibiotics (Basel). 2024 Aug 22;13(8):789. doi: 10.3390/antibiotics13080789.
4
Enterococcus faecium: evolution, adaptation, pathogenesis and emerging therapeutics.屎肠球菌:进化、适应、发病机制和新兴治疗方法。
Nat Rev Microbiol. 2024 Nov;22(11):705-721. doi: 10.1038/s41579-024-01058-6. Epub 2024 Jun 18.
5
The Relationship Between the Microbiome and Antimicrobial Resistance.微生物组与抗菌药物耐药性的关系。
Clin Infect Dis. 2023 Dec 5;77(Suppl 6):S479-S486. doi: 10.1093/cid/ciad641.
Front Microbiol. 2019 Jul 25;10:1704. doi: 10.3389/fmicb.2019.01704. eCollection 2019.
4
Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and Enterococcus casseliflavus/flavescens.非粪肠球菌和非屎肠球菌耐万古霉素肠球菌感染的临床管理。重点关注鹑鸡肠球菌和格氏/微黄肠球菌。
J Infect Chemother. 2018 Apr;24(4):237-246. doi: 10.1016/j.jiac.2018.01.001. Epub 2018 Feb 1.
5
Economic burden of nosocomial infections caused by vancomycin-resistant enterococci.耐万古霉素肠球菌引起的医院感染的经济负担。
Antimicrob Resist Infect Control. 2018 Jan 5;7:1. doi: 10.1186/s13756-017-0291-z. eCollection 2018.
6
The rapid spread of carbapenem-resistant Enterobacteriaceae.耐碳青霉烯类肠杆菌科细菌的快速传播。
Drug Resist Updat. 2016 Nov;29:30-46. doi: 10.1016/j.drup.2016.09.002. Epub 2016 Sep 19.
7
Vancomycin-Resistant Enterococci: Epidemiology, Infection Prevention, and Control.耐万古霉素肠球菌:流行病学、感染预防与控制
Infect Dis Clin North Am. 2016 Dec;30(4):953-965. doi: 10.1016/j.idc.2016.07.009. Epub 2016 Sep 19.
8
Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).耐碳青霉烯类肠杆菌科细菌(CRE)中异质性耐药机制对感染控制的影响
Expert Rev Anti Infect Ther. 2016;14(1):95-108. doi: 10.1586/14787210.2016.1106940. Epub 2015 Nov 4.
9
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management.耐万古霉素肠球菌感染:流行病学、临床表现及最佳管理
Infect Drug Resist. 2015 Jul 24;8:217-30. doi: 10.2147/IDR.S54125. eCollection 2015.
10
Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.产碳青霉烯酶肠杆菌科细菌引起的感染:危险因素、临床特征及预后
Enferm Infecc Microbiol Clin. 2014 Dec;32 Suppl 4:41-8. doi: 10.1016/S0213-005X(14)70173-9.